Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

In vitro and in vivo characterization of [177Lu]DOTA-G-02113 and [68Ga]DOTA-G-02113 presented

Oct. 17, 2019

Weak albumin-binding PSMA radioligands for improved prostate cancer therapy

Oct. 16, 2019

Novel PSMA-targeting 177-Lu radiolabeled compounds with outstanding tumor uptake presented

Oct. 15, 2019

[68Ga]FAPI-04 imaging evaluated in studies in cancer patients

Oct. 14, 2019

Novel near-infrared probe of biliary anatomy for image-guided hepatic surgery

Sep. 30, 2019

[68Ga]PCTA-DSPE radiolabeled chelator for atherosclerosis PET imaging

Sep. 26, 2019

Affibody collaborates with GE Healthcare to develop Affibody-based PET imaging tracers

Sep. 20, 2019

Life Molecular Imaging opens enrollment for phase II trial of next-generation tau PET tracer PI-2620

Sep. 17, 2019

Panitumumab-IRDye800 in phase II for metastatic lymph node identification in HNSCC

Sep. 3, 2019

Spago Nanomedical initiates first clinical trial of SN-132D

Aug. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...